Metastatic cancer-related thrombotic microangiopathies: A cohort study

Future Oncology

Volumn 10, Issue 10, 2014, Pages 1727-1734

  Ducos, Guillaume ^a   Mariotte, Eric ^a   Galicier, Lionel ^a   Canet, Emmanuel ^a   Boutboul, David ^a   Lemiale, Virginie ^a   Schlemmer, Benoit ^a   Veyradier, Agnes ^b   Azoulay, Elie ^a   Zafrani, Lara ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

cancer metastasis; thrombotic microangiopathy; thrombotic thrombocytopenic purpura

Indexed keywords

ANTITHROMBOCYTIC AGENT; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; PROTHROMBIN; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ABDOMINAL PAIN; ACUTE RESPIRATORY FAILURE; ADULT; AGED; ANOREXIA; ARTICLE; ARTIFICIAL VENTILATION; BONE MARROW BIOPSY; BONE PAIN; CANCER PROGNOSIS; CARDIOVASCULAR SYMPTOM; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FEVER; HEMOGLOBIN BLOOD LEVEL; HUMAN; IDIOPATHIC DISEASE; INTENSIVE CARE UNIT; LABORATORY TEST; LIFE SUSTAINING TREATMENT; MALE; METASTASIS; NEUROLOGIC DISEASE; PARTIAL THROMBOPLASTIN TIME; SOLID TUMOR; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; CASE REPORT; COMPLICATION; MIDDLE AGED; NEOPLASM; PATHOLOGY; THROMBOTIC MICROANGIOPATHIES; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS; THROMBOTIC MICROANGIOPATHIES; TREATMENT OUTCOME;

EID: 84907927116     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.14.113     Document Type: Article

References (18)

1. Kiss JE. Thrombotic thrombocytopenic purpura: Recognition and management. Int. J. Hematol. 91(1), 36-45 (2010).
2. Moake JI. Thrombotic microangiopathies. N. Eng. J. Med. 347(8), 589-600 (2002).
3. Gordon LI, Kwaan HC. Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient. Semin. Thromb. Hemost. 25(2), 217-221 (1999).
4. Oberic L, Buffet M, Schwarzinger M et al. Cancer awareness in atypical thrombotic microangiopathies. Oncologist 14(8), 769-779 (2009).
5. Elliott MA, Letendre L, Gastineau DA, Winters Jl, Pruthi RK, Heit JA. Cancer-Associated microangiopathic hemolytic anemia with thrombocytopenia: An important diagnostic consideration. Eur. J. Haematol. 85(1), 43-50 (2010).
6. Chang JC, Naqvi T. Thrombotic thrombocytopenic purpura associated with bone marrow metastasis and secondary myelofibrosis in cancer. Oncologist 8(4), 375-380 (2003).
7. Ferrari S, Scheiflinger F, Rieger M et al. Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity. Blood 109(7), 2815-2822 (2007).
8. Vincent Jl, Moreno R, Takala J et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intens. Care Med. 22(7), 707-710 (1996).
9. Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T. FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br. J. Haematol. 129(1), 93-100 (2005).
10. Darmon M, Azoulay E, Thiery G et al. Time course of organ dysfunction in thrombotic microangiopathy patients receiving either plasma perfusion or plasma exchange. Crit. Care Med. 34(8), 2127-2133 (2006).
11. Francis KK, Kalyanam N, Terrell DR, Vesely SK, George JN. Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist 12(1), 11-19 (2007).
12. Gonsalves WI, Gupta V, Smeltzer JP, Singh PP, McWilliams RR, Gangat N. Gallbladder cancer-Associated thrombotic microangiopathy. Future Oncol. 9(11), 1711-1715 (2013).
13. Lechner K, Obermeier Hl. Cancer-related microangiopathic hemolytic anemia: Clinical and laboratory features in 168 reported cases. Medicine (Baltimore) 91(4), 195-205 (2012).
14. Colman RW, Rubin RN. Disseminated intravascular coagulation due to malignancy. Semin. Oncol. 17(2), 172-186 (1990).
15. Robier C, Neubauer M, Beham-Schmid C, Sill H. Thrombotic microangiopathy and disseminated intravascular coagulation associated with carcinocythemia in a patient with breast cancer. J. Clin. Oncol. 29(34), e825-e826 (2011).
16. Von Bubnoff N, Sandherr M, Schneller F, Peschel C. Thrombotic thrombocytopenic purpura in metastatic carcinoma of the breast. Am J. Clin. Oncol. 23(1), 74-77 (2000).
17. Shao B, Wahrenbrock Mg, Yao L et al. Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome. Blood 118(15), 4015-4023 (2011).
18. Werner Tl, Agarwal N, Carney HM, Rodgers GM. Management of cancer-Associated thrombotic microangiopathy: What is the right approach?. Am. J. Hematol. 82(4), 295-298 (2007).